Zai Lab Limited
ZLAB
$18.61
-$0.49-2.57%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.32% | 38.29% | 13.70% | 49.27% | 9.41% |
| Total Depreciation and Amortization | 14.05% | 29.16% | 35.88% | 27.00% | 14.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -103.87% | -56.83% | 163.63% | -53.42% | 8.24% |
| Change in Net Operating Assets | 202.65% | 112.18% | -255.94% | -2,791.41% | 38.90% |
| Cash from Operations | 80.69% | 53.34% | -19.47% | 26.44% | 31.53% |
| Capital Expenditure | 22.10% | 73.96% | -123.92% | -289.34% | -57.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 65.52% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -106.44% | 96.92% | 96.21% | 36.57% | 7,580.90% |
| Cash from Investing | -106.83% | 96.75% | 86.45% | -245.39% | 9,806.83% |
| Total Debt Issued | 10.42% | 7.07% | 48.54% | 0.81% | 111.18% |
| Total Debt Repaid | -73.22% | -1,097,500.00% | -12,000.35% | -- | -- |
| Issuance of Common Stock | -72.32% | -99.89% | 55.21% | 19,070.45% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | -- | -22.00% |
| Cash from Financing | -87.08% | -100.18% | -50.74% | -60.36% | -9.27% |
| Foreign Exchange rate Adjustments | 1,755.00% | 123.46% | -65.49% | 418.18% | 119.23% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -109.19% | 77.42% | -8.27% | -20.56% | 881.29% |